{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 6,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 9,
        "Specificity": 7,
        "Sector_Spread": 8,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Gilead Sciences (GILD) announces promising Phase III trial results for its new antiviral drug, boosting market confidence in its pipeline.",
            "Correlation": 10,
            "Sentiment": 8,
            "Importance": 9,
            "Impact": 7,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 9,
            "Specificity": 10,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Biogen (BIIB) reports mixed Q3 earnings with revenue slightly below expectations but strong guidance for Q4.",
            "Correlation": 9,
            "Sentiment": 5,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Celgene (CELG) partners with a leading biotech firm to develop innovative cancer treatments, expanding its therapeutic portfolio.",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 6,
            "Duration": 7,
            "Virality": 4,
            "Source_Score": 9,
            "Specificity": 9,
            "Sector_Spread": 8,
            "Tech_Mentions": 3
        },
        {
            "News_content": "Amgen (AMGN) launches a new initiative aimed at reducing healthcare costs through more efficient drug delivery systems.",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 5,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Regeneron Pharmaceuticals (RGEN) sees increased institutional investor interest following recent positive analyst coverage.",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 6,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        }
    ]
}